Impact of "critical lesions" on outcomes following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
Ben-Yaacov A, Laks S, Goldenshluger M, Nevo Y, Mor E, Schtrechman G, Margalit O, Boursi B, Shacham-Shmueli E, Halpern N, Purim O, Hazzan D, Segev L, Zippel D, Adileh M, Nissan A.
Ben-Yaacov A, et al. Among authors: nissan a.
Eur J Surg Oncol. 2021 Nov;47(11):2933-2938. doi: 10.1016/j.ejso.2021.05.022. Epub 2021 May 19.
Eur J Surg Oncol. 2021.
PMID: 34088586